MedTrace Logo

Avenir Complete Post-Market Clinical Follow-Up Study

NCT04731077 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 275

Last updated 2025-06-18

No results posted yet for this study

Summary

The main objectives of this study are to confirm the long-term safety, performance and clinical benefits the Avenir Complete femoral stem and its instrumentation when used in primary total, hemi, and revision hip arthroplasty.

Conditions

  • Osteoarthritis, Hip
  • Avascular Necrosis of Hip
  • Avascular Necrosis of the Femoral Head
  • Post-traumatic; Arthrosis

Interventions

DEVICE

Avenir Complete Femoral Stem

All enrolled subjects will receive the Avenir Complete Femoral Stem

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-27
Primary Completion
2035-06-01
Completion
2036-06-01
FDA Device
Yes

Countries

  • United States
  • Denmark
  • Japan
  • Netherlands
  • Norway
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04731077 on ClinicalTrials.gov